Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to a randomized, multicenter phase II study of pembrolizumab in combination with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:36:29.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    43%
    Check dated 2024-05-22T21:21:30.000Z thumbnail image
  7. Check
    36 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the estimated study completion date, which is now projected to be in 2026 instead of the previous estimate. This change indicates a potential shift in the timeline for when the study on Pembrolizumab in combination with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma may conclude.
    Difference
    0.1%
    Check dated 2024-05-04T09:42:20.000Z thumbnail image
  8. Check
    37 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '2023 31 Submitted Estimated' to '2024 02 Posted Actual'. This change indicates that the results have been updated and posted with actual data, possibly related to medical and healthcare publications.
    Difference
    3%
    Check dated 2024-05-03T07:48:23.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:27:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.